RBC Capital raised the firm’s price target on Chemed (CHE) to $667 from $633 and keeps an Outperform rating on the shares after its Q4 earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results